Alzheimer's Disease Research News

---

• An in-depth look at how a unique collaborative effort changed the way researchers find and diagnose Alzheimer’s
  An in-depth look at how a unique collaborative effort changed the way researchers find and diagnose Alzheimer’s.
  Full Story >>
  
• Dr. Paul Aisen, Director of the ADCS, encourages people to get involved in clinical trials so preventative treatments for Alzheimer's disease can be developed
  © Alzheimer's Association International Conference on Alzheimer's Disease 2010.
  Video >>
  
• Rules Seek to Expand Diagnosis of Alzheimer’s
  Rules Seek to Expand Diagnosis of Alzheimer’s.
  Full Story >>
  
• Brain Scan and Dye Can Show AD Plaques That Build Up in Brains of People with Alzheimer’s
  A small start-up company might have overcome of the biggest obstacles in diagnosing Alzheimer’s.
  Full Story >>
  
• Predicting progression of Alzheimer's disease
  Professor Rachelle Doody and a team of researchers at Baylor College of Medicine have developed an evaluation that reliably predicts future cognition performance and activities of daily living in people with Alzheimer’s disease.
  Full Story >>
  
• Alzheimer's Disease Imaged Long Before Symptoms Appear
  Brain imaging finds signs of Alzheimer’s disease years before symptoms develop.
  Full Story >>
  
• Continuing Medical Education Dementia Conference
  The Memory Disorders Program at Georgetown University is presenting a continuing education dementia conference on February 26, 2010 at the Intercultural Center Auditorium, Georgetown University.
  Full story >>
• Predictors of Physician Referral for Patient Recruitment to Alzheimer Disease Clinical Trials
  Inadequate recruitment into AD clinical trials is an important threat to the validity and generalization of studies. Understanding physician perceptions of clinical trials is key to the success of a clinical trial.
  Full story >>
• Recovery Funds Advance Alzheimer's Disease Research
  American Recovery and Reinvestment Funds are being used to promote the national research efforts to better understand, diagnose and treat Alzheimer's disease.
  Full Story >>
  
• Alzheimer's Biomarker Initiative Hits Its Stride
  An effort to develop biomarkers for Alzheimer's disease is churning out new data and making plans to expand.
  Full Story >>
  
• Skills tests like 'connect the dots' may be early Alzheimer's indicator
  Researchers at Washington University in St. Louis found that declines in learning skills and other types of thinking may precede Alzheimer's memory loss.
  Full Story >>
  
• Key Brain Receptors Linked To Learning and Memory Decrease with Age
  Yale researchers find that important brain receptors are linked to learning and memory decline with age.
  Full Story >>
  
• 7th Leonard Berg Symposium October 1 - 2, 2009
  Presymptomatic Detection of Dominantly Inherited Alzheimer's Disease.
  Full Story >>
  
• Does Caffeine Help Decrease Beta-Amyloid in Alzheimer's Disease?
  Back-to-back studies published in the Journal of Alzheimer's Disease, show caffeine significantly decreased abnormal levels of beta-amyloid, the protein linked to Alzheimer's disease, both in the brains and in the blood of mice exhibiting symptoms of the disease.
  Full Story >>
  
• Early Warning: Key Alzheimer's Brain Changes Observed In Unimpaired Older Humans
  New research has uncovered an early disruption in the process of memory formation in older humans who exhibit some early brain changes associated with Alzheimer's disease (AD) but show little or no memory impairment.
  Full Story >>
  
• Video Gallery: The HBO Alzheimer's Project, Alzforum Series
  As part of HBO's The Alzheimer's Project 18 short films were developed to accompany the longer length films. These short films can be viewed on the Alzheimer's Research Forum website. They discuss a broad range of Alzheimer's disease research topics.
  Full Story >>
  
• Measuring Brain Atrophy in Patients with Mild Cognitive Impairment
  Measuring Brain Atrophy in Patients with Mild Cognitive Impairment Scientists at the University of California, San Diego (UCSD) School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size.
  Full Story >>
  
• Medical Information in the News: Can You Trust What You Read?
  Read the newspaper. Watch television or surf the internet. Medical information abounds. Some is scientifically sound, some based on opinion, and some is incomplete or even misrepresented.
  Full Story >>
  
• Update on Recent Developments Regarding Clinical Treatment Trials and Biomarkers
  A number of promising new treatments for Alzheimer's disease (AD) have migrated from early development in the laboratory to being tested in humans.
  Full Story >>
  
• The Pulse of Drug Development (HBO Film Documentary)
  We sit down with the director of the Alzheimer's Disease Cooperative Study of the National Institute on Aging to answer questions about the progress being made in drug development, the benefits of participating in clinical trials, and the research being done on herbal remedies.
  Full Story >>
  
• Searching for an Alzheimer's Cure: The Story of Flurizan (HBO Film Documentary)
  This film gives us a behind-the-scenes look at the largest Alzheimer's drug trial to date, what the results were, and what it means for the field.
  Full Story >>
  
• Does Neuroglobin Play a Role in Alzheimer's Disease?
  Neuroglobin is a protein that was first identified in 2000. It is a member of the globin family, similar to hemoglobin (which carries oxygen inside red blood cells) and myoglobin (which carries oxygen inside muscle cells).
  Full Story >>
  
• Picower-led Team Pinpoints Gene Key to Alzheimer's-like Reversal
  An MIT research team at the Picower Institute for Learning and Memory has identified the gene responsible for the 2007 discovery in which mice with Alzheimer's-like symptoms regained long-term memories and the ability to learn.
  Full Story >>
  
• Dr. Paul Aisen Interviewed by San Diego Union Tribune
  Dr. Paul Aisen of the ADCS is interviewed by Scott LaFee at the San Diego Union Tribune about the current state of Alzheimer's disease research.
  Full Story >>
  
• Results of the Ginkgo Biloba Phase III Trial
  Results of a large, six-year long, randomized trial showed no beneficial effect of Ginkgo biloba in the prevention of Alzheimer's disease or dementia in subjects with normal cognition or in those with mild cognitive impairment.
  Full story >>
• Women with Alzheimer's More Adversely Affected than Men
  A new study has found that women with Alzheimers are more adversely affected than men with the same condition.
  Full story >>
• New Study Examines Alzheimer's Caregiving in Late-Life Re-Marriages
  Ann Arbor, Michigan - Late-life remarriage complicates caring for an ailing spouse, according to a University of Michigan researcher who is conducting one of the first known studies to focus on the challenges facing older remarried caregivers - a growing segment of the older U.S. population.
  Full story >>
• U.S. Postal Service Issues Alzheimer's Stamp
  The U.S. Postal Service recently issued an Alzheimer's stamp to raise awareness of the brain-wasting disease and to draw attention to the vital role of the caregiver.
  Full story >>
• Why the Amyloid Hypothesis is Alive and Well
  There has been much discussion in the news lately as to whether the amyloid hypothesis is the correct path for research.
  Full story >>
• Study Finds Improved Cognitive Health among Older Americans
  Rates of cognitive impairment among older Americans are on the decline, according to a new study supported by the National Institutes of Health (NIH) comparing the cognitive health of older people in 1993 and 2002.
  Full story >>
• Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions
  It is fitting that this issue of Alzheimer's & Dementia honors the life and work of our friend and colleague, Dr. Leon Thal. Leon's research career, in important and perhaps some surprising ways.
  Full story >>
• Vitamin B Does Not Slow Cognitive Decline in Alzheimer's
  Washington (Reuters) - High doses of B vitamins failed to slow cognitive decline in people with Alzheimer's disease, dashing the hopes for a new weapon against the fatal, mind-robbing ailment, U.S. researchers said on Tuesday.
  Full story >>
• Recent Advances in AD Neurobiology
  Among the major uncertainties surrounding Alzheimer's disease is whether and how the amyloid plaques found in the brains of patients with the disorder actually damage neurons.
  Full story >>